Ferric pyrophosphate citrate administered via dialysate reduces erythropoiesis-stimulating agent use and maintains hemoglobin in hemodialysis patients.

Gupta A, Lin V, Guss C, Pratt R, Ikizler TA, Besarab A
Kidney Int. 2015 88 (5): 1187-94

PMID: 26154926 · PMCID: PMC4653585 · DOI:10.1038/ki.2015.203

MeSH Terms (14)

Adult Aged Dialysis Solutions Diphosphates Double-Blind Method Female Hematinics Hemoglobins Humans Iron Male Middle Aged Renal Dialysis Trace Elements

Connections (1)

This publication is referenced by other Labnodes entities:

Links